Genistein exhibits therapeutic potential for PCOS mice via the ER-Nrf2-Foxo1-ROS pathway
| Autor: | Yu-Si Wang, Bin Guo, Lian-Wen Zheng, Zhan-Peng Yue, Man Luo, Zhan-Qing Yang, Ji-Cheng Huang |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Estrous cycle
endocrine system medicine.medical_specialty Antioxidant endocrine system diseases medicine.medical_treatment Genistein FOXO1 Promoter Ovary General Medicine female genital diseases and pregnancy complications chemistry.chemical_compound Endocrinology medicine.anatomical_structure chemistry Internal medicine medicine Secretion Intracellular Food Science |
| Zdroj: | Food & Function. 12:8800-8811 |
| ISSN: | 2042-650X 2042-6496 |
| DOI: | 10.1039/d1fo00684c |
| Popis: | Polycystic ovarian syndrome (PCOS) is a complex endocrinopathy in women of reproductive age and the main cause of female infertility, but there is no universal drug for PCOS therapy. As a predominant dietary isoflavone present in soybeans, genistein (GEN) possesses estrogenic and antioxidative properties, but limited information is available regarding its therapeutic potential and underlying molecular mechanism in PCOS. In this study, we found that GEN might restore the estrous cycle of PCOS mice and ameliorate the elevation of circulating T, AMH and LH levels as well as LH/FSH ratios along with reduced cystic follicles, indicating the importance of GEN in PCOS therapy. Meanwhile, GEN improved the ovarian secretion function of PCOS mice and attenuated oxidative damage of the ovary through enhancing its antioxidant capability dependent on ER. Supplementation of GEN improved the defect of the ATP level and mitochondrial membrane potential, indicating the significance of GEN in preventing mitochondrial dysfunction. Further analysis demonstrated that GEN via ER heightened the expression of Nrf2 and Foxo1 whose blockage antagonized the defence of GEN on the secretory and mitochondrial functions of ovarian granulosa cells followed by the limited antioxidant capability and increased intracellular ROS level. Moreover, nuclear translocation and transcriptional activity of Nrf2 presented a notable enhancement after exposure to GEN. Addition of the Nrf2 inhibitor ML385 hampered the GEN induction of Foxo1. Nrf2 might directly bind to the antioxidant response element of the Foxo1 promoter region. Collectively, GEN might exhibit therapeutic potential for PCOS mice via the ER-Nrf2-Foxo1-ROS pathway. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|